Health Topics – Johns Hopkins Medicine Podcasts

If you have a severe allergy to one food, you probably have the same issues with other foods, as well as allergies to things like pollen that you inhale. That’s according to Robert Wood, principal investigator on a study that …

Severe food allergies do not usually occur alone, Elizabeth Tracey reports Read More »

Food allergies are very often multiple and begin in childhood. Does this mean the newly approved omalizumab, given by injection, must be taken for the rest of someone’s life? Robert Wood, principal investigator on the study used by the FDA …

Are injections to keep food allergies under control a lifelong prospect? Elizabeth Tracey reports Read More »

The FDA has just approved a drug called omalizumab used to treat asthma to treat multiple, severe food allergy. Robert Wood, an allergy expert at Johns Hopkins and principal investigator on the study that demonstrated the drug’s efficacy, says the …

Having allergies to many foods may make using a newly approved drug practical, Elizabeth Tracey reports Read More »

A drug called omalizumab has just been approved to treat severe food allergies. Robert Wood, Johns Hopkins allergy expert and principal investigator on a study proving the efficacy of this drug, says it’s needed because the strategy of feeding increasing …

Can food allergies be overcome by feeding foods people are allergic to? Elizabeth Tracey reports Read More »

Omalizumab is the chemical name for Xolair, an asthma medication that’s been around for decades that has just gotten FDA approval to treat food allergy. Robert Wood, an allergy expert at Johns Hopkins and one author of a recent study …

A newly approved drug to treat food allergy may be a game changer, Elizabeth Tracey reports Read More »

Myc, ras, BRCA…these are all shorthand for common cancer mutations, with a new study saying that’s how cancers should be identified rather than which organ or system they’re found in, since not knowing the mutations may delay proper treatment. Kimmel …

Should cancers be named according to which mutations they carry? Elizabeth Tracey reports Read More »

All cancers carry mutations, and these should direct how they are named, NOT where they are located. That’s the stance of a new study finding that treatments that are targeted to the actual mutations a cancer carries rely on identifying …

Should cancers be named differently? Elizabeth Tracey reports Read More »

More cancers were diagnosed in 2023 than in the previous year, the American Cancer Society says, but cancer deaths are not rising at the same rate. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says as our …

Reducing cancer rates will rely on a more complete understanding of what causes the disease, Elizabeth Tracey reports Read More »

While overall cancer deaths are continuing their decline, there are three that are still problematic, the most recent data from the American Cancer Society demonstrates. Johns Hopkins Kimmel Cancer Center director William Nelson names them. Nelson: The ones to watch …

Deaths from certain cancers continue to rise, Elizabeth Tracey reports Read More »

The annual analysis of the American Cancer Society reports that while the overall number of new cancers diagnosed is higher than last year, deaths from cancers are not rising along with the new cases. Sidney Kimmel Cancer center director William …

The American Cancer Society reports many new cancers but not rising deaths, Elizabeth Tracey reports Read More »